Table 5 Predictors of ischemic stroke and/or all-cause mortality in patients with AF attending GUH, 2017 (N = 159)

Clinical type

NVAF

3.374 (1.321–8.614)

0.011

0.784 (0.194–3.167)

0.733

Age

in years

1.039 (1.019–1.060)

0.000

1.035 (1.004–1.067)

0.029

CHF

Yes

0.223 (0.119–0.416)

0.000

0.347 (0.105–1.141)

0.081

Hypertension

Yes

1.970 (1.097–3.536)

0.023

1.117 (0.410–3.042)

0.828

History of stroke/TIA

Yes

0.371 (0.133–1.036)

0.058

0.038 (0.002–0.596)

0.020

Cardiomegaly

Yes

0.484 (0.225–1.040)

0.063

0.843 (0.316–2.244)

0.732

LVEF

in %

1.033 (1.006–1.061)

0.017

1.051 (0.998–1.106)

0.059

Any type of Valvular disease

Yes

0.429 (0.234–0.788)

0.006

1.757 (0.660–4.679)

0.259

 Paroxysmal

–

–

–

–

 Persistent

0.361 (0.158–0.826)

0.016

1.293 (0.287–5.830)

0.738

 Longstanding persistent

0.016 (0.003–0.074)

0.000

0.002 (0.000–1.875)

0.075

ASA

Yes

0.443 (0.231–0.850)

0.014

1.179 (0.256–5.426)

0.832

Warfarin

Yes

0.099 (0.030–0.320)

0.000

0.294 (0.033–2.642)

0.275

Digoxin

Yes

0.300 (0.151–0.597)

0.001

1.259 (0.678–2.337)

0.465

Atenolol

Yes

0.146 (0.057–0.373)

0.000

0.139 (0.017–1.125)

0.064

Enalapril

Yes

0.364 (0.143–0.926)

0.034

1.395 (0.087–22.248)

0.814

Furosemide

Yes

0.201 (0.101–0.397)

0.000

0.416 (0.057–3.008)

0.385

Spironolactone

Yes

0.149 (0.063–0.354)

0.000

0.121 (0.013–1.134)

0.064